Page last updated: 2024-12-08

10,12-tricosadiynoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

## 10,12-Tricosadiynoic acid (TDA)

**10,12-Tricosadiynoic acid (TDA)** is a naturally occurring fatty acid with two triple bonds at carbons 10 and 12, giving it a distinctive diyne structure. It is found in various plants and microorganisms, notably in certain species of *Chrysanthemum* and *Artemisia*.

**Why is TDA important for research?**

TDA possesses a unique combination of properties that makes it interesting for various fields of research, including:

**1. Biological Activity:**

* **Antimicrobial activity:** TDA has shown significant activity against various bacteria and fungi, potentially serving as a source for new antimicrobial agents.
* **Antifungal activity:** TDA exhibits potent antifungal activity, particularly against the opportunistic fungal pathogen *Candida albicans*.
* **Anti-inflammatory activity:** Some studies suggest that TDA may possess anti-inflammatory properties.
* **Cytotoxicity:** TDA has shown cytotoxicity against certain cancer cell lines, suggesting potential therapeutic applications.

**2. Chemical Properties:**

* **Unique structure:** The diyne structure of TDA contributes to its distinct chemical reactivity and potential for chemical modifications.
* **Self-assembly properties:** TDA has demonstrated self-assembly properties, forming organized structures like nanotubes and micelles. This property makes it promising for applications in materials science.
* **Luminescence:** TDA exhibits luminescence, making it potentially useful for fluorescence-based sensing and imaging applications.

**3. Potential Applications:**

* **Development of novel antibiotics and antifungals:** TDA's antimicrobial properties make it a promising candidate for developing new therapeutic agents to combat resistant pathogens.
* **Nanomaterials and drug delivery:** The self-assembly properties of TDA could lead to the development of novel nanomaterials for targeted drug delivery and controlled release.
* **Bioimaging and diagnostics:** The luminescence of TDA could be harnessed for bioimaging and diagnostic applications.

**Ongoing Research:**

Research on TDA is ongoing in several areas, including:

* Understanding its mechanism of action against microbes and cancer cells.
* Developing new synthetic methods to produce TDA efficiently.
* Exploring its potential applications in various fields, including medicine, materials science, and biotechnology.

**Overall, 10,12-tricosadiynoic acid is a fascinating molecule with unique properties and promising potential for various applications.** Its biological activity, chemical properties, and potential applications make it a subject of continued research and development.

Cross-References

ID SourceID
PubMed CID538457
CHEBI ID190947
SCHEMBL ID302150
MeSH IDM0398414

Synonyms (19)

Synonym
AKOS015839844
10,12-tricosadiynoic acid
10,12-tricosadiynoic acid, >=98.0% (gc)
66990-30-5
T1200
tricosa-10,12-diynoic acid
CHEBI:190947
10,12-tricosadiynoicacid
FT-0607184
SCHEMBL302150
10,12- tricosadiynoic acid
mfcd00041683
DTXSID40337084
CS-0112754
HY-135425
10,12-tricosadiynoic acid, >/=98%
d-saccharicacid1,4-lactone
D92469
PD127433
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
very long-chain fatty acidA fatty acid which has a chain length greater than C22. Very long-chain fatty acids which have a chain length greater than C27 are also known as ultra-long-chain fatty acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (57.14)29.6817
2010's5 (35.71)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.41

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.41 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.41)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]